Drug intelligence / Profile preview

达斯玛保丸

Development stage: Unknown
Lead developer: Jiumei Tibetan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

达斯玛保丸 (Dasimabao Wan) is a traditional Tibetan medicine herbal formulation developed and manufactured by Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd. It is an oral pill composed of 15 herbal ingredients, including iron mallet (铁棒锤), purple grass (紫草茸), Tibetan madder (藏茜草), sickle-shaped milk vetch (镰形棘豆), and musk (麝香). The formulation is designed to clear heat, detoxify, and provide anti-inflammatory and antimicrobial effects. It is indicated for the treatment of various infectious and inflammatory conditions, including meningitis, influenza, pneumonia, pharyngitis, and epidemic diseases. As a traditional multi-component herbal product, its specific molecular mechanisms and biological targets have not been characterized in modern pharmacological terms.

Brand names: 达斯玛保丸
Other names: Dasimabao Wan

Beyond the preview

Go deeper on 达斯玛保丸.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 达斯玛保丸.

Explore the full profile